Study design & results
Available in the Gosset platform where reported.
Trial intelligence / Profile preview
Rivaroxaban versus warfarin for carotid plaque in non-valvular atrial fibrillation
IRCT20190729044372N1Phase 3Completed
- Sponsor
- Kermanshah University of Medical Sciences
- Start
- Mar 2019
- Modality
- Small Molecules
- Countries
- 1
01
Overview
Phase 3, randomised, open-label trial in Atrial fibrillation (AFib), stroke, transient ischaemic attack (TIA) and 1 more comparing Rivaroxaban arm with Warfarin arm (2 arms). Primary endpoints: Carotid plaque size, Internal carotid stenosis grade and 3 more. Started Mar 2019; status: completed.
02
Drugs
rivaroxabanwarfarin
03
Conditions
Atrial fibrillation (AFib)stroketransient ischaemic attack (TIA)carotid atheroma (CAS)
Beyond the preview
Go deeper on IRCT20190729044372N1.
Study design, results and competitive context are available in the Gosset platform where reported.
Competitive context
Available in the Gosset platform where reported.
Bring the full picture into focus.
See how Gosset can support your research on IRCT20190729044372N1.